• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Urgent: Reminder to Level II ABMs from CZ

Anonymous

Guest
Hello!
CZ here, just a friendly reminder that you L2 folks are receiving $2500 LESS than your harding working LEVEL III NEW HIRES for making goal. Thanks for training them! Now go out there and give me a full day you lousy second class reps! Love. CZ
PS- Let me know if I can demoralize you in any other way- I was once a sales rep myself you know!
PSS- Sales are down but my actions should reverse this trend.